Senior Early Development Asset Lead
Listed on 2026-10-18
-
Science
Research Scientist
Ipsen Biopharm Ltd appoints an Early Development Asset Lead to drive integrated strategy across preclinical to first-in-human stages. The role leads the EDT, coordinating clinical, regulatory, CMC, translational, and biomarker activities to ensure rigorous, evidence-based program progression with portfolio alignment.
Strong scientific leadership, external evaluation experience, and a track record in oncology drug development are essential.
Our team is growing, and we are hiring a Senior Early Development Asset Lead in United Kingdom.
The position is based in United Kingdom.
This opportunity is part of our work in Bio & Pharmacology & Health.
The advertised compensation is 120..
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.
Learn more about the Senior Early Development Asset Lead role in the description above.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).